Garnet Anderson

Appointments and Affiliations

 
 
Fred Hutchinson Cancer Research Center
Public Health Sciences Division
Senior Vice President and Director, Appointed: 2013
 
Fred Hutchinson Cancer Research Center
Public Health Sciences Division
Cancer Prevention
Member, Appointed: 2002
 
University of Washington
School of Public Health and Community Medicine
Biostatistics
Affiliate Associate Professor, Appointed: 1997

Mailing Address

1100 Fairview Ave. N.
Mailstop M3-A410
P.O. Box 19024
Seattle, Washington 98109
United States

Contact

Phone: (206) 667-4699
Fax: (206) 667-4142
garnet@whi.org

Degrees

Ph.D., University of Washington, Biostatistics, 1989.
M.S., State University of New York at Binghamton, Mathematics, 1983.

Research Interests

My interests and areas of expertise are:
Design, analysis, and conduct of randomized trials
Biostatistics
Women's health
Chronic disease prevention research
Ovarian cancer, including biomarkers, screening, and risk
 

Memberships

American Statistical Association
International Biometric Society
Society for Controlled Clinical Trials

Previous Positions

1995-2002, Associate Member, Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Biostatistics
1989-1995, Assistant Member, Fred Hutchinson Cancer Research Center, Biostatistics, Public Health Sciences
1989-1997, Affiliate Assistant Professor, University of Washington, Public Health, Biostatistics

Funding

  • National Cancer Institute: Estimating Risk of Ovarian Cancer, Oct 1, 2001 to Sep 30, 2004.

 

Recent Publications

2014
Karlan, BY, Thorpe JD, Watabayashi K, Drescher CW, Palomares MR, Daly M, Paley PJ, Hillard PJ, Andersen MR, Anderson GL et al..  2014.  Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
2013
Chlebowski, RT, Nikolaenko L, Anderson G.  2013.  Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings.. The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists. 39(3):226-8.